Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Technology Trust Regulatory News (PCT)

Share Price Information for Polar Capital Technology Trust (PCT)

Share Price is delayed by 15 minutes
Get Live Data
702.00    0.00 (0.00%)
Bid:
641.00
Ask:
710.00
Spread: 69.00 (10.764%)
Market Cap: £7.79b
PCT Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Technology Trust Share Chart

Annual Overview from QuotedData

26 Feb 2026 16:18

RNS Number : 5927U
Polar Capital Technology Trust PLC
26 February 2026
 

 

Polar Capital Technology - Annual Overview from QuotedData

26 February 2026

At the foothills of an AI mountain

Over the past year, Polar Capital Technology (PCT) has strongly outperformed its benchmark, with its NAV total return nearly double that of the Dow Jones Global Tech Index. This reflects the success of its bold AI-focused strategy, where it has taken large positions in lesser-known companies expected to benefit from AI infrastructure bottlenecks, while selling those it sees as less promising.

This approach has driven strong returns recently and helped PCT avoid losses as markets reacted to plans for increased spending during 2026 by major US tech firms. While debate continues over whether the sector is in a bubble, PCT's manager believes we are still at the early stages of AI growth, supported by rapid innovation such as Alphabet's Gemini 3 launch and rising enterprise adoption, which is expected to accelerate with agentic AI (AI that can run autonomously with little human input and can act like a proactive assistant, planning, reasoning and taking multi-step actions to achieve complex goals).

Full Research:

https://quoteddata.com/research/polar-capital-technology-at-the-foothills-of-an-ai-mountain-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Polar Capital Technology Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKAKAFSKEFA
Date   Source Headline
24th Feb 20255:10 pmRNSTransaction in Own Shares
24th Feb 202512:20 pmRNSNet Asset Value(s)
21st Feb 20255:23 pmRNSTransaction in Own Shares
21st Feb 202512:07 pmRNSNet Asset Value(s)
20th Feb 202512:02 pmRNSNet Asset Value(s)
19th Feb 20255:04 pmRNSTransaction in Own Shares
19th Feb 202512:06 pmRNSNet Asset Value(s)
18th Feb 20255:13 pmRNSTransaction in Own Shares
18th Feb 202511:32 amRNSNet Asset Value(s)
17th Feb 20251:30 pmRNSNet Asset Value(s)
14th Feb 202511:51 amRNSNet Asset Value(s)
13th Feb 202512:44 pmRNSNet Asset Value(s)
12th Feb 20255:11 pmRNSTransaction in Own Shares
12th Feb 202512:03 pmRNSNet Asset Value(s)
11th Feb 20255:06 pmRNSTransaction in Own Shares
11th Feb 202512:05 pmRNSNet Asset Value(s)
10th Feb 20255:10 pmRNSTransaction in Own Shares
10th Feb 20251:13 pmRNSNet Asset Value(s)
7th Feb 20255:10 pmRNSTransaction in Own Shares
7th Feb 202512:59 pmRNSNet Asset Value(s)
6th Feb 20255:09 pmRNSTransaction in Own Shares
6th Feb 20253:43 pmRNSTop Fifteen Equity Holdings and Exposures
6th Feb 202512:16 pmRNSNet Asset Value(s)
5th Feb 20255:20 pmRNSTransaction in Own Shares
5th Feb 202511:43 amRNSNet Asset Value(s)
4th Feb 20255:56 pmRNSTransaction in Own Shares
4th Feb 202512:12 pmRNSNet Asset Value(s)
3rd Feb 202511:57 amRNSNet Asset Value(s)
3rd Feb 202510:56 amRNSTotal Voting Rights
3rd Feb 20258:30 amRNS-RPolar Capital Technology enters the FTSE 100 Index
31st Jan 20251:48 pmRNSNet Asset Value(s)
30th Jan 20251:00 pmRNSHolding(s) in Company
30th Jan 202512:20 pmRNSNet Asset Value(s)
29th Jan 20256:00 pmRNSSmith (DS)
29th Jan 202511:56 amRNSNet Asset Value(s)
28th Jan 20251:58 pmRNSNet Asset Value(s) - Replacement
28th Jan 202512:46 pmRNSNet Asset Value(s)
27th Jan 202512:07 pmRNSNet Asset Value(s)
24th Jan 202512:34 pmRNSNet Asset Value(s)
23rd Jan 20255:17 pmRNSTransaction in Own Shares
23rd Jan 202511:57 amRNSNet Asset Value(s)
22nd Jan 20255:09 pmRNSTransaction in Own Shares
22nd Jan 20252:09 pmRNSFactsheet
22nd Jan 202512:07 pmRNSNet Asset Value(s)
21st Jan 20255:34 pmRNSTransaction in Own Shares
21st Jan 202511:18 amRNSNet Asset Value(s)
20th Jan 202512:20 pmRNSNet Asset Value(s)
17th Jan 20255:02 pmRNSTransaction in Own Shares
17th Jan 202512:01 pmRNSNet Asset Value(s)
16th Jan 20251:24 pmRNS-RAnnual Overview from QuotedData

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.